Article info
PDFReviews
Alzheimer's disease: mimics and chameleons
- Correspondence to Dr Jonathan M Schott, Dementia Research Centre, Institute of Neurology, UCL, London WC1N 3BG, UK, j.schott{at}ucl.ac.uk
Citation
Alzheimer's disease: mimics and chameleons
Publication history
- Received April 19, 2012
- Accepted July 21, 2012
- First published November 8, 2012.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Biomarkers in dementia: clinical utility and new directions
- Dementia
- Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease
- An algorithmic approach to structural imaging in dementia
- Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage
- Presenile dementia syndromes: an update on taxonomy and diagnosis
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- Brain imaging in dementia
- Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis